CureVac NV (5CV.DE) Sharpe Ratio

Sharpe ratio is not yet available for 5CV.DE. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares CureVac NV's Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how 5CV.DE's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Apr 3, 2026.

Symbol	Name	1Y Sharpe Ratio
BBZA.DE	BB Biotech AG	2.43
NP5.DE	NEWRON PHARMACEUT. EO-20	2.12
0QF.DE	Moderna, Inc.	0.86
BNN.DE	BRAIN Biotech AG	0.08
HPHA.DE	Heidelberg Pharma AG	0.04
22UA.DE	BioNTech SE	-0.17
FYB.DE	Formycon AG	-0.43
5CV.DE	CureVac NV	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows 5CV.DE's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when 5CV.DE consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading graphics...